First Trust Direct Indexing L.P. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
First Trust Direct Indexing L.P. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$410,161
+42.4%
11,371
+50.8%
0.05%
+35.3%
Q1 2023$288,000
-31.7%
7,541
+1.7%
0.03%
-39.3%
Q4 2022$421,743
+47.5%
7,412
+2.5%
0.06%
+33.3%
Q3 2022$286,000
-10.1%
7,2300.0%0.04%
-4.5%
Q2 2022$318,000
+7.4%
7,230
-2.7%
0.04%
+22.2%
Q1 2022$296,000
+13.0%
7,427
+14.0%
0.04%
+5.9%
Q4 2021$262,000
-0.4%
6,516
+0.6%
0.03%
-8.1%
Q3 2021$263,000
-23.3%
6,475
-14.2%
0.04%
-27.5%
Q2 2021$343,000
+63.3%
7,546
+50.0%
0.05%
-8.9%
Q1 2021$210,000
+4.0%
5,030
+6.5%
0.06%
+3.7%
Q4 2020$202,0004,7220.05%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders